Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
July 31, 2023 8:15 AM 2 min read

Jim Cramer Doesn't Think China Can Deflate With Its 'Guns And Butter' Strategy: 'Lousy Combination'

by Shanthi Rexaline Benzinga Editor
Follow
MCHI Logo
MCHIiShares MSCI China ETF
$60.34-0.02%
Overview

The Chinese economy has failed to gain any decent momentum following the reopening from stricter COVID-19 lockdowns in Dec. 2022. Macroeconomic indicators vouch for this fact.

Weak data has prompted the communist regime of the country to promise stimulus measures to kickstart growth.

CNBC Mad Money host Jim Cramer on Monday said, “China can keep trying to stimulate but can it have a guns and butter strategy and still deflate.”

“Guns-and-butter” is a phrase used to refer to a government's dilemma in apportioning spending between defense and social programs.

Apparently, the stock picker finds it hard to believe that the government spends lavishly on both defense and social programs and still has a deflationary environment.

Data released by the China National Bureau of Statistics showed that consumer prices remained unchanged in June relative to the year-ago period and producer prices fell 5.4%, marking the ninth consecutive month.

See Also: Best Chinese Stocks

"Military and luxury spend stimulation are a lousy combination," Cramer said. He also questioned whether "Belt & Road" will still be a priority after the more than $200 billion spent on stimuli.

China's Belt and Road Initiative, also known as the New Silk Road, is an ambitious infrastructure project launched in 2013 aimed at increasing China's economic and political clout. It was originally devised to link East Asia and Europe through physical infrastructure and the project has now brought within its ambit Africa, Oceania, and Latin America.

When China hinted that it will implement measures to revitalize the slumping property market earlier this month, Cramer said, “A stimulus policy based on home buying in a no-growth economy has been a sucker’s bet every time. Only the West buys into it. But we don’t live there.”

The iShares MSCI China ETF (NASDAQ:MCHI) edged up 0.26% to $49.61 in premarket trading, according to Benzinga Pro data.

Read Next: ‘China Has 10 Years Left, At Most’ — 100 Million Population Drop Could Lead To Economic Disaster, According To Famed Analyst

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
AsiaNewsPoliticsGlobalTop StoriesEconomicsChinaEurasia
MCHI Logo
MCHIiShares MSCI China ETF
$60.34-0.02%
Overview
Comments
Loading...